Insider Transactions last 24 months for Taysha Gene Therapies, Inc.  -  NSDQ: TSHA

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Alam KamranCHIEF FINANCIAL OFFICER02/04/2026DSDirectCOM1,655$4.52$7,480.601,442,131
Nolan Sean P.Chief Executive Officer01/26/2026DSDirectCOM41,312$4.61$190,448.322,908,257
Nagendran SukumarPresident and Head of R&D01/26/2026DSDirectCOM26,918$4.61$124,091.981,317,389
Alam KamranCHIEF FINANCIAL OFFICER01/26/2026DSDirectCOM23,849$4.61$109,943.891,443,786
Nolan Sean P.Chief Executive Officer01/23/2026DSDirectCOM136,789$4.75$649,747.752,949,569
Nagendran SukumarPresident and Head of R&D01/23/2026DSDirectCOM89,132$4.75$423,377.001,344,307
Alam KamranCHIEF FINANCIAL OFFICER01/23/2026DSDirectCOM78,968$4.75$375,098.001,467,635
Nolan Sean P.Chief Executive Officer01/12/2026AADirectCOM1,008,000$0.00$0.003,086,358
Nagendran SukumarPresident and Head of R&D01/12/2026AADirectCOM427,000$0.00$0.001,433,439
Nagendran SukumarPresident and Head of R&D01/12/2026DSDirectCOM200,000$4.71$942,000.001,006,439
Nagendran SukumarPresident and Head of R&D01/12/2026AMDirectCOM88,676$1.71$151,635.961,206,439
Nagendran SukumarPresident and Head of R&D01/12/2026AMDirectCOM111,324$0.70$77,804.341,117,763
Alam KamranCHIEF FINANCIAL OFFICER01/12/2026AADirectCOM359,000$0.00$0.001,546,603
Nagendran SukumarPresident and Head of R&D12/01/2025DSDirectCOM260,047$4.51$1,172,811.971,006,439
Nagendran SukumarPresident and Head of R&D12/01/2025AMDirectCOM260,047$1.71$444,680.371,266,486
Nagendran SukumarPresident and Head of R&D11/28/2025DSDirectCOM110,125$4.75$523,093.751,006,439
Nagendran SukumarPresident and Head of R&D11/28/2025AMDirectCOM39,953$1.71$68,319.631,116,564
Nagendran SukumarPresident and Head of R&D11/28/2025AMDirectCOM70,172$0.70$49,043.211,076,611
Nagendran SukumarPresident and Head of R&D09/10/2025DSDirectCOM200,000$3.23$646,000.001,006,439
Nagendran SukumarPresident and Head of R&D09/10/2025AMDirectCOM41,150$0.70$28,759.741,206,439
Alam KamranCHIEF FINANCIAL OFFICER08/21/2025DSDirectCOM54,491$2.85$155,299.351,187,603
Nagendran SukumarPresident and Head of R&D08/21/2025DSDirectCOM57,054$2.85$162,603.901,165,289
Sepp-Lorenzino LauraDirector06/02/2025AADirectCOM56,623$0.00$0.00105,843
Long Alison SDirector06/02/2025AADirectCOM56,623$0.00$0.00105,843
Donenberg Phillip B.Director06/02/2025AADirectCOM56,623$0.00$0.00219,954
1   2  Next Last  You are at page 1 of 2 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel